Document is current

Chapter History

First Online: 19 September 2025

Disclosure of Interests

: The authors declare the following competing interests: G.B.M. is a scientific advisory board member or consultant for Amphista, Astex, AstraZeneca, BlueDot, Chrysallis Biotechnology, Ellipses Pharma, GSK, ImmunoMET, Infinity, Ionis, Leapfrog Bio, Lilly, Medacorp, Nanostring, Nuvectis, PDX Pharmaceuticals, Qureator, Roche, Signalchem Lifesciences, Tarveda, Turbine, and Zentalis Pharmaceuticals. G.B.M. holds stock, stock options, or other financial interests in Bluedot, Catena Pharmaceuticals, ImmunoMet, Nuvectis, SignalChem, Tarveda, and Turbine. G.B.M. has licensed technology including the HRD assay to Myriad Genetics and DSP patents with Nanostring, and has sponsored research with AstraZeneca. The other authors declare no competing interests relevant to the content of this article.

Conference Information

Conference Acronym: MICCAI

Conference Name: International Conference on Medical Image Computing and Computer-Assisted Intervention

Conference City: Daejeon

Conference Country: Korea (Republic of)

Conference Year: 2025

Conference Start Date: 23 September 2025

Conference End Date: 27 September 2025

Conference Number: 28

Conference ID: miccai2025

Conference URL: https://conferences.miccai.org/2025/